268P Results from a real-world study of patients (pts) with hormone-receptor (HR)-positive HER2-negative metastatic breast cancer (MBC) treated with CDK4/6 inhibitors (CDK 4/6i) in three institutions

Autor:	H. Pla, S. Recalde Penabad, G. Vinas Villaro, M. Margeli Vila, V.L. Obadia Gil, B. Cirauqui Cirauqui, S. Del Barco Berron, M.J. Gil, V. Quiroga Garcia, I. Teruel-Garcia, S. Pernas Simon, A. Stradella, A.M. Esteve Gomez, E. Felip
Rok vydání:	2022
Předmět:	Oncology Hematology
Zdroj:	Annals of Oncology. 33:S660
ISSN:	0923-7534
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::39fe4f100799e4889c125e0624dec0bd https://doi.org/10.1016/j.annonc.2022.07.307 Zobrazit plný text záznamu